6/7/2025

Janusmed sex and gender

Janusmed sex and gender – Cholestyramine

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
A A
A A

Cholestyramine

Cholestyramine

Class : A

Show all info

Print

Contact us

  1. Levy RI, Fredrickson DS, Stone NJ, Bilheimer DW, Brown WV, Glueck CJ et al. Cholestyramine in type II hyperlipoproteinemia A double-blind trial. Ann Intern Med. 1973;79:51-8.

  2. The Lovastatin Study Group. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia The Lovastatin Study Group III. JAMA. 1988;260:359-66.

  3. Eriksson M, Hådell K, Holme I, Walldius G, Kjellström T. Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care. J Intern Med. 1998;243:373-80.

  4. Statistikdatabas för läkemedel. Stockholm: Socialstyrelsen. 2022 [cited 2023-03-02.]

  1. Levy RI, Fredrickson DS, Stone NJ, Bilheimer DW, Brown WV, Glueck CJ et al. Cholestyramine in type II hyperlipoproteinemia A double-blind trial. Ann Intern Med. 1973;79:51-8.
  2. The Lovastatin Study Group. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia The Lovastatin Study Group III. JAMA. 1988;260:359-66.
  3. Eriksson M, Hådell K, Holme I, Walldius G, Kjellström T. Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care. J Intern Med. 1998;243:373-80.
  4. Statistikdatabas för läkemedel. Stockholm: Socialstyrelsen. 2022 [cited 2023-03-02.]